Skip to main content
Monika (Dwivedi) Joshi, MD, Oncology, Hershey, PA

Monika(Dwivedi)JoshiMDMRCP

Oncology Hershey, PA

Hematologic Oncology

Associate Professor

Dr. Joshi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Joshi's full profile

Already have an account?

  • Office

    500 University Dr
    Penn State Hershey Cancer Institute
    Hershey, PA 17033
    Phone+1 717-531-8678

Education & Training

  • Penn State Milton S Hershey Medical Center
    Penn State Milton S Hershey Medical CenterFellowship, Hematology and Medical Oncology, 2010 - 2013
  • UPMC Medical Education (Harrisburg)
    UPMC Medical Education (Harrisburg)Residency, Internal Medicine, 2007 - 2010
  • Kasturba Medical College Manipal
    Kasturba Medical College ManipalClass of 2001

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2007 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Original Contribution Mitotic Activity in Non-Invasive Papillary Urothelial Carcinoma: Its Value in Predicting Tumor Recurrence, and Comparison to the Contemporary Two...  
    Augustyna Gogoj, Suzanne B Merrill, Monika Joshi, Sheldon Holder, Joshua I Warrick, Matthew Kaag, Jay D Raman, Joseph Drabick, ScienceDirect

Authored Content

  • Advances in Treatments for Genitourinary Malignancies Provide Silver Lining to 2020October 2020

Press Mentions

  • Monika Joshi, MD, on Geographic Disparities in Urothelial Cancer Care
    Monika Joshi, MD, on Geographic Disparities in Urothelial Cancer CareJuly 1st, 2022
  • Need for a Personalized Approach for Muscle Invasive Bladder Cancer: Role of Tumor Biology in Response to Neoadjuvant Chemotherapy
    Need for a Personalized Approach for Muscle Invasive Bladder Cancer: Role of Tumor Biology in Response to Neoadjuvant ChemotherapyDecember 4th, 2018
  • DDR Mutations Linked to Improved Urothelial Cancer Outcomes
    DDR Mutations Linked to Improved Urothelial Cancer OutcomesJune 15th, 2019
  • Join now to see all